Antihormonal Therapy Market Forecasts

Antihormonal cancer therapies are used predominantly in the treatment of breast and prostate cancers. The high incidence of these tumors translates into a significant commercial potential for drug developers. In seven major pharmaceutical markets, the antihormonal therapy cancer brands generated $7 billion in 2009.

Reasons to Purchase

• Quantify the performance of the marketed antihormonal therapy cancer brands in the seven major markets over the period 2009 to 2019.
• Acquire a detailed account of antihormonal therapy cancer brand dynamics and the events that drive and limit their market growth.
• Benchmark antihormonal therapy cancer brands against their generics and rest of class, and align their $7 billion performance with a rest of world snapshot.

Datamonitor